Natural Health Trends Corp is an international direct-selling and e-commerce company... Show more
The 10-day moving average for NHTC crossed bearishly below the 50-day moving average on June 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where NHTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
NHTC moved below its 50-day moving average on July 08, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for NHTC entered a downward trend on July 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for NHTC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Momentum Indicator moved above the 0 level on July 03, 2025. You may want to consider a long position or call options on NHTC as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for NHTC just turned positive on July 03, 2025. Looking at past instances where NHTC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NHTC advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .
NHTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.704) is normal, around the industry mean (4.253). P/E Ratio (114.250) is within average values for comparable stocks, (50.740). NHTC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.426). Dividend Yield (0.175) settles around the average of (0.098) among similar stocks. P/S Ratio (1.229) is also within normal values, averaging (6.688).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NHTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a developer of natural health products
Industry InternetRetail
A.I.dvisor indicates that over the last year, NHTC has been loosely correlated with BHHOF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NHTC jumps, then BHHOF could also see price increases.
Ticker / NAME | Correlation To NHTC | 1D Price Change % | ||
---|---|---|---|---|
NHTC | 100% | -0.65% | ||
BHHOF - NHTC | 34% Loosely correlated | N/A | ||
DIBS - NHTC | 21% Poorly correlated | -1.42% | ||
CVNA - NHTC | 21% Poorly correlated | -1.58% | ||
BYON - NHTC | 21% Poorly correlated | +1.64% | ||
QVCGP - NHTC | 20% Poorly correlated | -2.03% | ||
More |